These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36539463)

  • 1. Optimal uric acid reduction to improve vascular endothelial function in patients with chronic heart failure complicated by hyperuricemia.
    Naganuma J; Sakuma M; Kitahara K; Kato T; Yokomachi J; Yamauchi F; Inoue R; Iida K; Kohno Y; Inoue K; Koshiji N; Abe S; Toyoda S; Inoue T;
    Hypertens Res; 2023 Mar; 46(3):688-696. PubMed ID: 36539463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of xanthine oxidase inhibitor in patients with chronic heart failure complicated with hyperuricemia: a prospective randomized controlled clinical trial of topiroxostat vs allopurinol-study protocol.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T;
    Clin Exp Nephrol; 2018 Dec; 22(6):1379-1386. PubMed ID: 29916098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Open-Label, Cross-Over Comparison of the Effects of Benzbromarone and Febuxostat on Endothelial Function in Patients with Hyperuricemia.
    Nakata T; Ikeda S; Koga S; Yonekura T; Tsuneto A; Doi Y; Fukae S; Minami T; Kawano H; Maemura K
    Int Heart J; 2020 Sep; 61(5):984-992. PubMed ID: 32921665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies.
    Doehner W; Schoene N; Rauchhaus M; Leyva-Leon F; Pavitt DV; Reaveley DA; Schuler G; Coats AJ; Anker SD; Hambrecht R
    Circulation; 2002 Jun; 105(22):2619-24. PubMed ID: 12045167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of endothelial function between conduit artery and microvasculature in patients with coronary artery disease.
    Tajima E; Sakuma M; Tokoi S; Matsumoto H; Saito F; Watanabe R; Toyoda S; Abe S; Inoue T
    Cardiol J; 2020; 27(1):38-46. PubMed ID: 30155869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of Endothelial Function after Minor-to-Moderate Surgery Is Impaired by Diabetes Mellitus, Obesity, Hyperuricemia and Sevoflurane-Based Anesthesia.
    Ohno S; Kohjitani A; Miyata M; Tohya A; Yamashita K; Hashiguchi T; Ohishi M; Sugimura M
    Int Heart J; 2018 May; 59(3):559-565. PubMed ID: 29681567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition.
    Harzand A; Tamariz L; Hare JM
    Congest Heart Fail; 2012; 18(3):179-82. PubMed ID: 22587748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.
    Mercuro G; Vitale C; Cerquetani E; Zoncu S; Deidda M; Fini M; Rosano GM
    Am J Cardiol; 2004 Oct; 94(7):932-5. PubMed ID: 15464681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of topiroxostat on vascular function in patients with hyperuricemia.
    Higa S; Shima D; Tomitani N; Fujimoto Y; Kario K
    J Clin Hypertens (Greenwich); 2019 Nov; 21(11):1713-1720. PubMed ID: 31556223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uric acid in chronic heart failure.
    Doehner W; Anker SD
    Semin Nephrol; 2005 Jan; 25(1):61-6. PubMed ID: 15660337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does overnight duty affect vascular endothelial function?
    Garu A; Nitta E; Yoshida Y; Yata E; Tsunematsu A; Araki T; Nagai A; Yano S
    BMC Cardiovasc Disord; 2021 Sep; 21(1):467. PubMed ID: 34579658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
    Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
    Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changeover Trial of Febuxostat and Topiroxostat for Hyperuricemia with Cardiovascular Disease: Sub-Analysis for Chronic Kidney Disease (TROFEO CKD Trial).
    Sezai A; Unosawa S; Taoka M; Osaka S; Sekino H; Tanaka M
    Ann Thorac Cardiovasc Surg; 2020 Aug; 26(4):202-208. PubMed ID: 31748427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric Acid Is a Biomarker of Oxidative Stress in the Failing Heart: Lessons Learned from Trials With Allopurinol and SGLT2 Inhibitors.
    Packer M
    J Card Fail; 2020 Nov; 26(11):977-984. PubMed ID: 32890737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Function and Uric Acid-Lowering in Stage 3 CKD.
    Jalal DI; Decker E; Perrenoud L; Nowak KL; Bispham N; Mehta T; Smits G; You Z; Seals D; Chonchol M; Johnson RJ
    J Am Soc Nephrol; 2017 Mar; 28(3):943-952. PubMed ID: 27620990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
    Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
    Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.
    Sakuma M; Toyoda S; Arikawa T; Koyabu Y; Kato T; Adachi T; Suwa H; Narita JI; Anraku K; Ishimura K; Yamauchi F; Sato Y; Inoue T
    PLoS One; 2022; 17(1):e0261445. PubMed ID: 35077456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.
    Cicero AFG; Caliceti C; Fogacci F; Giovannini M; Calabria D; Colletti A; Veronesi M; Roda A; Borghi C
    Mol Nutr Food Res; 2017 Nov; 61(11):. PubMed ID: 28755406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of uric acid on vascular endothelial function from bedside to bench.
    Otani N; Toyoda S; Sakuma M; Hayashi K; Ouchi M; Fujita T; Anzai N; Tanaka A; Node K; Uemura N; Inoue T
    Hypertens Res; 2018 Nov; 41(11):923-931. PubMed ID: 30185927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.